SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Phaarmasia - Quaterly Results

25 May 2023 Evaluate
The topline surged 80.19% to Rs. 75.03 millions for the March 2023 quarter as against Rs. 41.64 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -0.93 millions as compared to Net Loss of Rs. -1.49 millions of corresponding quarter ended March 2022 Operating profit Margin for the quarter ended March 2023 further decreased to -0.69% as compared to -0.80% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 75.03 41.64 80.19 274.90 172.16 59.68 274.90 172.16 59.68
Other Income 1.41 1.54 -8.44 5.16 4.70 9.79 5.16 4.70 9.79
PBIDT -0.69 -0.80 -13.75 -10.27 -12.65 -18.81 -10.27 -12.65 -18.81
Interest 0.32 0.01 3100.00 0.45 0.04 1025.00 0.45 0.04 1025.00
PBDT -1.01 -0.81 24.69 -10.72 -12.69 -15.52 -10.72 -12.69 -15.52
Depreciation 1.70 0.72 136.11 3.60 2.92 23.29 3.60 2.92 23.29
PBT -2.71 -1.53 77.12 -14.32 -15.61 -8.26 -14.32 -15.61 -8.26
TAX -1.78 -0.04 4350.00 -1.73 -0.15 1053.33 -1.73 -0.15 1053.33
Deferred Tax -1.78 -0.04 4350.00 -1.73 -0.15 1053.33 -1.73 -0.15 1053.33
PAT -0.93 -1.49 -37.58 -12.59 -15.46 -18.56 -12.59 -15.46 -18.56
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -0.92 -1.92 -52.13 -3.74 -7.35 -49.16 -3.74 -7.35 -49.16

Phaarmasia Share Price

113.80 1.80 (1.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×